SPF
GILD icon

South Plains Financial’s Gilead Sciences GILD Stock Holding History

South Plains Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47
Closed -$6.55K – 217
2026
Q1 		$6.55K Sell
47
-371
-89% -$52K ﹤0.01% 210
2025
Q4 		$51.3K Buy
+418
New +$50.8K 0.03% 175
2025
Q1 		– Sell
-155
Closed -$14.3K – 249
2024
Q4 		$14.3K Buy
+155
New +$14K 0.01% 194

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

South Plains Financial's GILD Position: Q2 2026 in Review

South Plains Financial sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 47 shares — an estimated $6.55K sold.

South Plains Financial first reported a position in GILD in Q4 2024 and held it in 3 quarters. The position peaked at $51.3K in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • South Plains Financial reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • South Plains Financial sold 47 Gilead Sciences shares in Q2 2026, an estimated $6.55K.
  • South Plains Financial first reported a position in Gilead Sciences in Q4 2024 and held it in 3 quarters.
  • South Plains Financial's Gilead Sciences position peaked at $51.3K in Q4 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on South Plains Financial's 13F filing for Q2 2026, filed 13 Aug 2026.